Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 102

1.

Clinical characteristics and outcomes of octogenarians presenting with ST elevation myocardial infarction in the Australian population.

Sim WL, Mutha V, Ul-Haq MA, Sasongko V, Van-Gaal W.

World J Cardiol. 2017 May 26;9(5):437-441. doi: 10.4330/wjc.v9.i5.437.

2.

The Applicability of the American College of Cardiology Appropriate Use Criteria for Myocardial Perfusion Scintigraphy in Australia.

Chow CL, Ponnuthurai FA, Allman KC, van Gaal W.

Heart Lung Circ. 2017 May 17. pii: S1443-9506(17)30341-4. doi: 10.1016/j.hlc.2017.04.006. [Epub ahead of print]

PMID:
28602670
3.

Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients.

Ridker PM, Revkin J, Amarenco P, Brunell R, Curto M, Civeira F, Flather M, Glynn RJ, Gregoire J, Jukema JW, Karpov Y, Kastelein JJP, Koenig W, Lorenzatti A, Manga P, Masiukiewicz U, Miller M, Mosterd A, Murin J, Nicolau JC, Nissen S, Ponikowski P, Santos RD, Schwartz PF, Soran H, White H, Wright RS, Vrablik M, Yunis C, Shear CL, Tardif JC; SPIRE Cardiovascular Outcome Investigators.

N Engl J Med. 2017 Apr 20;376(16):1527-1539. doi: 10.1056/NEJMoa1701488. Epub 2017 Mar 17.

PMID:
28304242
4.

Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease.

Sabatine MS, Giugliano RP, Keech AC, Honarpour N, Wiviott SD, Murphy SA, Kuder JF, Wang H, Liu T, Wasserman SM, Sever PS, Pedersen TR; FOURIER Steering Committee and Investigators.

N Engl J Med. 2017 May 4;376(18):1713-1722. doi: 10.1056/NEJMoa1615664. Epub 2017 Mar 17.

PMID:
28304224
5.

An unusual finding in the right atrium.

Chow CL, Chen SS, van Gaal W.

Heart. 2017 Jan 15;103(2):153. doi: 10.1136/heartjnl-2016-310301. Epub 2016 Sep 12.

PMID:
27619332
6.

Prevalence and outcomes of trans-radial access for percutaneous coronary intervention in contemporary practise.

Asrar Ul Haq M, Tsay IM, Dinh DT, Brennan A, Clark D, Cox N, Harper R, Nadurata V, Andrianopoulos N, Reid C, Duffy SJ, Lefkovits J, van Gaal WJ.

Int J Cardiol. 2016 Oct 15;221:264-8. doi: 10.1016/j.ijcard.2016.06.099. Epub 2016 Jun 28.

PMID:
27404687
7.

Comparison of international normalized ratio audit parameters in patients enrolled in GARFIELD-AF and treated with vitamin K antagonists.

Fitzmaurice DA, Accetta G, Haas S, Kayani G, Lucas Luciardi H, Misselwitz F, Pieper K, Ten Cate H, Turpie AG, Kakkar AK; GARFIELD-AF Investigators.

Br J Haematol. 2016 Aug;174(4):610-23. doi: 10.1111/bjh.14084. Epub 2016 Apr 12.

PMID:
27071942
8.

Effect of Losmapimod on Cardiovascular Outcomes in Patients Hospitalized With Acute Myocardial Infarction: A Randomized Clinical Trial.

O'Donoghue ML, Glaser R, Cavender MA, Aylward PE, Bonaca MP, Budaj A, Davies RY, Dellborg M, Fox KA, Gutierrez JA, Hamm C, Kiss RG, Kovar F, Kuder JF, Im KA, Lepore JJ, Lopez-Sendon JL, Ophuis TO, Parkhomenko A, Shannon JB, Spinar J, Tanguay JF, Ruda M, Steg PG, Theroux P, Wiviott SD, Laws I, Sabatine MS, Morrow DA; LATITUDE-TIMI 60 Investigators.

JAMA. 2016 Apr 19;315(15):1591-9. doi: 10.1001/jama.2016.3609.

PMID:
27043082
9.

Radiation dose difference between state of the art myocardial perfusion scintigraphy and computed tomography coronary angiography in patients undergoing evaluation for suspected coronary artery disease.

Tsay IM, Subiakto I, Asrar Ul Haq M, Castles AV, Allman K, Hayat U, Rudd N, Barlis P, van Gaal W.

Intern Med J. 2016 Feb;46(2):226-9. doi: 10.1111/imj.12969.

PMID:
26899890
10.

Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome.

Pfeffer MA, Claggett B, Diaz R, Dickstein K, Gerstein HC, Køber LV, Lawson FC, Ping L, Wei X, Lewis EF, Maggioni AP, McMurray JJ, Probstfield JL, Riddle MC, Solomon SD, Tardif JC; ELIXA Investigators.

N Engl J Med. 2015 Dec 3;373(23):2247-57. doi: 10.1056/NEJMoa1509225.

11.

N-terminal pro-B-type Natriuretic Peptides' Prognostic Utility Is Overestimated in Meta-analyses Using Study-specific Optimal Diagnostic Thresholds.

Potgieter D, Simmers D, Ryan L, Biccard BM, Lurati-Buse GA, Cardinale DM, Chong CP, Cnotliwy M, Farzi SI, Jankovic RJ, Lim WK, Mahla E, Manikandan R, Oscarsson A, Phy MP, Rajagopalan S, Van Gaal WJ, Waliszek M, Rodseth RN.

Anesthesiology. 2015 Aug;123(2):264-71. doi: 10.1097/ALN.0000000000000728. Review.

PMID:
26200179
12.

Practical experience with ticagrelor: an Australian and New Zealand perspective.

Harding SA, Van Gaal WJ, Schrale R, Gunasekara A, Amerena J, Mussap CJ, Aylward PE.

Curr Med Res Opin. 2015 Aug;31(8):1469-77. doi: 10.1185/03007995.2015.1058247. Epub 2015 Jun 30. Review.

PMID:
26086451
13.

Long-term survival of elderly patients undergoing percutaneous coronary intervention for myocardial infarction complicated by cardiogenic shock.

Lim HS, Andrianopoulos N, Sugumar H, Stub D, Brennan AL, Lim CC, Barlis P, Van Gaal W, Reid CM, Charter K, Sebastian M, New G, Ajani AE, Farouque O, Duffy SJ, Clark DJ; Melbourne Interventional Group.

Int J Cardiol. 2015 Sep 15;195:259-64. doi: 10.1016/j.ijcard.2015.05.130. Epub 2015 May 22.

PMID:
26048389
14.

Rationale, design, and baseline characteristics in Evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo.

Bentley-Lewis R, Aguilar D, Riddle MC, Claggett B, Diaz R, Dickstein K, Gerstein HC, Johnston P, Køber LV, Lawson F, Lewis EF, Maggioni AP, McMurray JJ, Ping L, Probstfield JL, Solomon SD, Tardif JC, Wu Y, Pfeffer MA; ELIXA Investigators.

Am Heart J. 2015 May;169(5):631-638.e7. doi: 10.1016/j.ahj.2015.02.002. Epub 2015 Feb 12.

PMID:
25965710
15.

Synchronous cardiac arrest in monozygotic twins with hypertrophic cardiomyopathy--is sudden cardiac death genetically pre-programmed?

Goh CY, Asrar ul Haq M, Mutha V, van Gaal WJ.

BMC Cardiovasc Disord. 2015 Feb 28;15:16. doi: 10.1186/s12872-015-0007-3.

16.

Long-term use of ticagrelor in patients with prior myocardial infarction.

Bonaca MP, Bhatt DL, Cohen M, Steg PG, Storey RF, Jensen EC, Magnani G, Bansilal S, Fish MP, Im K, Bengtsson O, Oude Ophuis T, Budaj A, Theroux P, Ruda M, Hamm C, Goto S, Spinar J, Nicolau JC, Kiss RG, Murphy SA, Wiviott SD, Held P, Braunwald E, Sabatine MS; PEGASUS-TIMI 54 Steering Committee and Investigators.

N Engl J Med. 2015 May 7;372(19):1791-800. doi: 10.1056/NEJMoa1500857. Epub 2015 Mar 14.

17.

Does sex affect anticoagulant use for stroke prevention in nonvalvular atrial fibrillation? The prospective global anticoagulant registry in the FIELD-Atrial Fibrillation.

Lip GY, Rushton-Smith SK, Goldhaber SZ, Fitzmaurice DA, Mantovani LG, Goto S, Haas S, Bassand JP, Camm AJ, Ambrosio G, Janský P, Al Mahmeed W, Oh S, van Eickels M, Raatikainen P, Steffel J, Oto A, Kayani G, Accetta G, Kakkar AK; GARFIELD-AF Investigators.

Circ Cardiovasc Qual Outcomes. 2015 Mar;8(2 Suppl 1):S12-20. doi: 10.1161/CIRCOUTCOMES.114.001556. Epub 2015 Feb 24.

18.

Bleeding risk and incidence in real world percutaneous coronary intervention patients with ticagrelor.

Subiakto I, Asrar ul Haq M, Van Gaal WJ.

Heart Lung Circ. 2015 Apr;24(4):404-6. doi: 10.1016/j.hlc.2014.10.006. Epub 2014 Oct 30. No abstract available.

PMID:
25465512
19.

Interaction between digoxin and dronedarone in the PALLAS trial.

Hohnloser SH, Halperin JL, Camm AJ, Gao P, Radzik D, Connolly SJ; PALLAS investigators.

Circ Arrhythm Electrophysiol. 2014 Dec;7(6):1019-25. doi: 10.1161/CIRCEP.114.002046. Epub 2014 Nov 6.

20.

Effects of intravenous caffeine on fractional flow reserve measurements in coronary artery disease.

Mutha V, Asrar Ul Haq M, Van Gaal WJ.

Open Heart. 2014 Aug 4;1(1):e000060. doi: 10.1136/openhrt-2014-000060. eCollection 2014.

Supplemental Content

Loading ...
Support Center